The FDA has warned consumers that the sexual enhancement supplement S.W.A.G. contains an undisclosed ingredient and should not be purchased or used.
Nova Products announced a voluntary recall of African Black Ant, Black Ant, XZen Gold, ZXen Platinum, XZen 1200, XZone Gold, and XZone 1200, products marketed as dietary supplements for sexual enhancement.
Researchers have coaxed human stem cells into becoming bladder cells that could aid in repairing defective or diseased bladders.
Prostate-specific antigen screening has decreased since publication of the U.S. Preventive Services Task Force Recommendations against screening
Resolved childhood glomerular disease is associated with increased subsequent risk of hypertension.
For patients with prostate cancer, stereotactic body radiation therapy is less expensive than intensity-modulated radiation therapy, but is associated with more genitourinary toxicity.
For women undergoing surgery for vaginal prolapse and stress urinary incontinence, outcomes for two common transvaginal approaches are comparable, and perioperative behavioral therapy with pelvic floor muscle training does not improve surgical outcomes
Over the last 25 years, pediatric kidney transplantation outcomes have improved in the United States.
The FDA has warned consumers that the sexual enhancement supplement Weekend Warrior contains an undisclosed ingredient and should not be purchased or used.
Baxter announced a voluntary recall of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II).
High concentrations of three common forms of phthalates in men have been shown to impact fertility in couples trying to conceive.
Ferumoxytol and iron sucrose have comparable safety in the treatment of anemia in patients with CKD.
For patients with established cardiovascular disease and atrial fibrillation, warfarin treatment correlates with a lower risk of a composite of death, myocardial infarction (MI), and ischemic stroke, with no increased risk of bleeding.
The DASH diet may be an effective alternative to the low-oxalate diet for reducing risk of kidney stone recurrence.
Thermal receipt handling is associated with increased urinary concentrations of bisphenol A (BPA).
For men with prostate cancer who are under active surveillance, repeated biopsies are associated with increased risk of infectious complications.
The FDA has accepted Auxilium's supplemental Biologics License Application (sBLA) for Xiaflex (collagenase clostridium histolyticum, or CCH) for the treatment of two Dupuytren's contracture (DC) cords concurrently.
For women with end-stage renal disease (ESRD), intensive hemodialysis is associated with improved pregnancy outcomes.
Tamoxifen that has been identified in samples of the dietary supplement Esto Suppress.
Bayer HealthCare announced that it has begun enrolling patients into the Phase 3 COAST trial studying Stivarga (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Changes in mental and emotional well-being occur in prostate cancer patients on androgen deprivation therapy (ADT).
Medivation and Astellas Pharma announced results from their Phase 3 PREVAIL trial of Xtandi (enzalutamide) in patients with chemotherapy-naive metastatic prostate cancer who have failed androgen deprivation therapy and have few or no symptoms.
The FDA is warning consumers that several sexual enhancement supplements have been found to contain hidden ingredients, and that these products should not be purchased or used.
Acute kidney injury (AKI) is seen in about 7% of patients undergoing percutaneous coronary intervention (PCI) and is associated with significant in-hospital mortality.
ZS Pharma announced top-line results from its Extended Treatment Phase of ZS003, a Phase 3 trial of ZS-9 for the treatment of hyperkalemia.
Auxilium announced that it has submitted a supplemental Biologics License Application (sBLA) to the FDA for Xiaflex (collagenase clostridium histolyticum) for the treatment of multiple Dupuytren's contracture (DC) cords concurrently.
Researchers found that GA alone correlated with significantly increased risk for systemic progression and elevated overall mortality within 90 postoperative days.
The FDA is warning the public that methylphenidate products may cause priapism.
For patients with castration-resistant prostate cancer (CRPC), a therapeutic framework should involve an integrated approach, with joint management by a urologist and medical oncologist
Both acute and chronic inflammation correlated significantly with a lower risk of PCa at the two-year biopsy,
New guidelines for lipid management in chronic kidney disease (CKD) recommend wider statin use.
The FDA has approved a new indication for Xiaflex (collagenase clostridium histolyticum; Auxilium) for the treatment of Peyronie's disease, a curvature deformity of the penis due to the presence of a plaque.
Higher and lower levels of testosterone (T) and its metabolites may raise mortality risk in older men.
Testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms for hypogonadal men.
Results from the CKiD Study found that children and adolescents with chronic kidney disease were less likely to grow to normal height ranges if they came from lower-income families, even with more prescriptions for growth hormone.
The FDA is warning consumers to not buy or use Alpha Male, a product sold for sexual enhancement.
Tendex is recalling one lot of P-Boost (Lot # F51Q) and one lot of NatuRECT (Lot # F51Q) after the FDA determined the products contained undeclared tadalafil. These products are sold as dietary supplements for sexual enhancement.
For patients with treatment-resistant hypertension and chronic kidney disease, renal denervation (RDN) reduces blood pressure (BP) and can slow renal function decline.
The FDA notified the public that Fossil Fuel Products and Jobbers Wholesale are voluntarily recalling some sexual enhancement supplements after they were found to contain several undeclared drug ingredients.
According to results from a National Institutes of Health-funded study, a commonly used stenting procedure in the renal artery appears to offer no significant improvement when added to medication-based therapy.
Micro-vessel disease in retina and kidneys are independently and interactively associated with higher risk of atrial fibrillation.
The FDA is warning the public about a potentially harmful counterfeit male sexual enhancement supplement called ExtenZe Maximum Strength.
But low levels of E. coli had a high positive predictive value for bladder bacteriuria.
According to a recent study, a gene variant commonly found in African-Americans predicts that people with that gene who also have chronic kidney disease (CKD) are twice as likely to progress to kidney failure as African-Americans without the high-risk gene and white people with CKD.
ZS Pharma has announced top-line results from the acute phase of its pivotal Phase 3 ZS-003 trial of ZS-9, an investigational treatment for hyperkalemia.
For older adults, co-prescription with clarithromycin vs. azithromycin and calcium-channel blockers is associated with increased risk of hospitalization with acute kidney injury.
Bardoxolone methyl does not reduce the risk of end-stage renal disease (ESRD) or cardiovascular death in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.
For first responders exposed to particulate matter at Ground Zero, high exposure is associated with albuminuria.
The FDA is advising consumers to not purchase or use Vitalikor Fast Acting, a sexual enhancement supplement sold on various websites and retail stores.
Testosterone therapy use was associated with an increased risk of adverse outcomes.
Over the last decade there has been an increase in the incidence of acute kidney injury (AKI), but a decrease in the incidence of AKI requiring dialysis, among elderly patients hospitalized with a heart attack who have undergone percutaneous coronary intervention.
United-Guardian announced that Renacidin Irrigation (citric acid, glucono delta-lactone, magnesium carbonate) is available again after a series of manufacturing issues.
Eli Lilly announced that the FDA has approved an addition to the Cialis (tadalafil) label to include data from a 26-week study that showed Cialis 5mg once daily started in combination with finasteride significantly improved the signs and symptoms of benign prostatic hyperplasia (BPH) as early as 4 weeks.
Use of integrated intensity-modulated radiation therapy (IMRT) has increased more among urologists in private practice.
Problematic symptoms of prostate biopsy can lead to increased anxiety in men, even when the biopsy results are negative for cancer.
The American College of Physicians (ACP) has presented recommendations for the screening, monitoring, and treatment of adults with chronic kidney disease.
Three-month scores on the Expanded Prostate Cancer Index Composite (EPIC) predict urinary and sexual functional outcomes at 12 months.
Moderate or severe psoriasis is associated with chronic kidney disease.
About 27% of the variance in whether a man received PSA screening was explained by which PCP was providing his care.
Men considering a vasectomy after the financial crisis in 2008 had significantly fewer children compared with men considering the procedure before the crisis.
Lifestyle behaviors such as caffeine and alcohol intake and physical activity may impact sperm quality parameters.
Male concentrations of phthalates correlate with diminished couple fecundability, while increased maternal conjugated bisphenol A (BPA) levels correlate with miscarriage.
Daily application of antibacterial honey at the exit site is not associated with increased time to peritoneal-dialysis-related infections.
Men in regions with the highest screening costs were significantly more likely to be diagnosed with prostate cancer and localized cancer.
The addition of the presence of complement-binding donor-specific anti-HLA antibodies to a traditional risk model improved the prediction of graft failure.
The prevalence of chronic kidney disease (CKD) has increased among U.S. adults aged ≥80 years.
Merck Consumer announced that Oxytrol for Women (oxybutynin transdermal system) is now available over-the-counter (OTC) to treat women with an overactive bladder.
The FDA is advising consumers not to purchase or use Xzen Xpress, Wood-E, or X-Zone Premium supplements because they were found to contain hidden drug ingredients.
The risk of adverse findings at surgery for men with very low risk (VLR) prostate cancer is significantly lower than for those with low risk (LR).
Prostate-specific antigen testing is more likely among affluent men.
Midurethral-sling surgery is more effective than physical therapy for women with stress urinary incontinence.
Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with type 2 diabetes.
The FDA has authorized the marketing of NeoTract Inc.'s UroLift system, a permanent implant to relieve low or blocked urine flow in men with an enlarged prostate.
Declines in testosterone levels as well as estradiol deficiences account for the clinical manifestations of testosterone deficiency in men.
Relypsa announced positive results for Part A of a two-part pivotal Phase 3 clinical trial evaluating patiromer for the treatment of hyperkalemia.
There has been an increase in women visiting the emergency room for kidney stones while hospitalization rates have remained stable.
Simple behavioral methods are effective for nocturnal enuresis in children but alarm therapy or some drug therapy may be more effective.
The FDA has requested that Hardmenstore.com voluntarily recall 1000 lots of 72HP, Evil Root, and Pro Power Max following the discovery of a hidden ingredient.
Wellness Pharmacy is voluntarily recalling certain lots of Dexpanthenol, Magnesium Sulfate, Methylcobalamin, Sodium Phenylbutyrate, R.L Glutathione, and Ascorbic Acid due to unreliable sterility results.
Exercise training and lifestyle intervention has beneficial effects on cardiorespiratory fitness, body composition, and diastolic function in patients with moderate chronic kidney disease (CKD).
There may be a bidirectional association between depression and nocturia.
In patients with chronic kidney disease (CKD), optimal blood pressure (BP) seems to be 130-159/70-89 mmHg.
Jack Rabbit is recalling one lot of its sexual enhancement supplement called Jack Rabbit after it was found to contain two undeclared ingredients.
The use of thromboprophylaxis in patients undergoing urological procedures is low among American Urological Association (AUA) members.
Researchers find no association in whites.
Percutaneous tibial nerve stimulation with the Urgent PC Neuromodulation System offers sustained overactive bladder symptom improvement after three years of therapy.
Eighteen months after receiving a kidney transplant, a recipient died from acute progressive encephalitis caused by rabies infection that had been undiagnosed in the donor.
Among women, a history of kidney stones is associated with an increased risk of coronary heart disease (CHD).
Erectile dysfunction (ED) has predictive value for cardiovascular risk and treatment may have beneficial effects.
After radical prostatectomy, men who received testosterone therapy for hypogonadism had a lower rate of biochemical recurrence than nonhypogonadal men.
Independent mutations have been identified in the dual serine-threonine and tyrosine protein kinase gene (DSTYK) in patients with congenital abnormalities of the kidney and urinary tract.
For men at high risk of biochemical recurrence after radical prostatectomy, daily consumption of a soy protein supplement is not associated with a reduction in the risk of recurrence.
Nearly two-thirds of men report an absence of shared decision making related to prostate-specific antigen (PSA) screening.
Compromised kidneys significantly reduce survival and life expectancy in patients with systemic lupus erythematosus (SLE).
A signature composed of three-gene mRNA in urinary cells can identify kidney biopsy samples showing acute cellular rejection.
Kidney involvement and high anti-double stranded (ds) DNA are independent predictors of moderate-severe lupus flare.
The FDA has taken action against over 9,600 websites for online sale and distribution of unapproved prescription medications to consumers.
For males who have had type 1 diabetes for ≥50 years, sexual dysfunction is associated with large vessel cardiovascular disease.
For post-acute coronary syndrome patients, the risk of kidney injury is comparable for those treated with an intensive or moderate statin regime.
Procysbi (cysteamine bitartrate delayed-release capsules; Raptor) has been made available for the management of nephropathic cystinosis.